Steven M. Rauscher is Director at ACORDA THERAPEUTICS INC (ACOR). They have made 5 open-market trades across 2 companies since 2007, most recently 2018-05-15.
CIK 0001166683
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $27K since 2007, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACOR | SELL | 2018-05-15 | 2018-05-17 | $24.59 | $246K | +8.7% | +26.9% | +15.5% |
| ACOR | SELL | 2017-08-01 | 2017-08-03 | $21.57 | $216K | -3.2% | -1.1% | +28.5% |
| ACOR | SELL · 10b5-1 | 2016-06-08 | 2016-06-10 | $27.83 | $30K | -6.3% | -5.2% | -7.8% |
| ACOR | SELL | 2015-03-04 | 2015-03-06 | $34.91 | $94K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL | 2010-08-05 | 2010-08-09 | $36.21 | $1.1M | -8.7% | +0.7% | +0.7% |
| OSCI | BUY | 2007-09-12 | 2007-09-14 | $2.71 | $27K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.